BMO Capital analyst Juan Sanabria downgraded CareTrust REIT (CTRE) to Market Perform from Outperform with a price target of $32, down from $34. Post the PACS allegations, the firm thinks it is “appropriate to take a breather.” PACS represents a significant 20% of the company’s pro-forma rents and has made up a significant piece of CareTrust’s external growth, the analyst tells investors in a research note. BMO sees potential risk to CareTrust’s PACS rent coverage, particularly new acquisitions, if billing policies change relative to expected underwriting.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTRE:
- CareTrust REIT Reports Strong Q3 2024 Results
- CareTrust REIT 13.8M share Spot Secondary priced at $32.00
- CareTrust REIT 11.5M share Spot Secondary; price range $31.50-$32.50
- CareTrust REIT announces 11.5M share common stock offering
- Ensign Group to add eight nursing operations in Tennessee, one in Alabama